Prevention of musculoskeletal disorders in workers: classification and health surveillance – statements of the Scientific Committee on Musculoskeletal Disorders of the International Commission on Occupational Health

BMC Musculoskeletal Disorders

Judith K Sluiter²  Brad Evanoff⁶  Judith Gold³  Alexis Descatha⁵  Roberta Bonfiglioli⁴  Francesco Saverio Violante⁴  Mats Hagberg¹ 

[1] Department of Public Health and Community Medicine, University of Gothenburg (UGOT), Box 414, SE 405 30, Gothenburg, Sweden;Academic Medical Centre, Department: Coronel Institute of Occupational Health, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands;Department of Public Health, Temple University, 1301 Cecil B. Moore Avenue, Ritter Annex, Philadelphia, PA 19122, USA;Occupational Health Unit, University of Bologna Sant’Orsola Malpighi Hospital via Palagi, 9, 40138, Bologna, Italy;Occupational Health Department/INSERM U1018-UVSQ Poincaré Teaching Hospital AP-HP, Garches, France;Division of General Medical Sciences, Washington University School of Medicine, Campus, Box 8005, 660 S, Euclid Ave., St. Louis, MO 63130, USA

关键词: Orthopaedics;    Rehabilitation;    Rheumatology;    Public health;    Occupational health;    Expert opinion;    Aetiology;    Prevention;    Epidemiology;    Occupation;   

Others  :  1149310
DOI  :  10.1186/1471-2474-13-109

 received in 2012-03-16, accepted in 2012-06-21,  发布年份 2012

【 摘 要 】

The underlying purpose of this commentary and position paper is to achieve evidence-based recommendations on prevention of work-related musculoskeletal disorders (MSDs). Such prevention can take different forms (primary, secondary and tertiary), occur at different levels (i.e. in a clinical setting, at the workplace, at national level) and involve several types of activities. Members of the Scientific Committee (SC) on MSDs of the International Commission on Occupational Health (ICOH) and other interested scientists and members of the public recently discussed the scientific and clinical future of prevention of (work-related) MSDs during five round-table sessions at two ICOH conferences (in Cape Town, South Africa, in 2009, and in Angers, France, in 2010). Approximately 50 researchers participated in each of the sessions. More specifically, the sessions aimed to discuss new developments since 1996 in measures and classification systems used both in research and in practice, and agree on future needs in the field.

The discussion focused on three questions: At what degree of severity does musculoskeletal ill health, and do health problems related to MSDs, in an individual worker or in a group of workers justify preventive action in occupational health? What reliable and valid instruments do we have in research to distinguish ‘normal musculoskeletal symptoms’ from ‘serious musculoskeletal symptoms’ in workers? What measures or classification system of musculoskeletal health will we need in the near future to address musculoskeletal health and related work ability?

Four new, agreed-upon statements were extrapolated from the discussions: 1. Musculoskeletal discomfort that is at risk of worsening with work activities, and that affects work ability or quality of life, needs to be identified. 2. We need to know our options of actions before identifying workers at risk (providing evidence-based medicine and applying the principle of best practice). 3. Classification systems and measures must include aspects such as the severity, frequency, and intensity of pain, as well as measures of impairment of functioning, which can help in prevention, treatment and prognosis. 4. We need to be aware of economic and/or socio-cultural consequences of classification systems and measures.

【 授权许可】

   
2012 Hagberg et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Kilbom S, Armstrong T, Buckle P, Fine L, Hagberg M, Haring-Sweeney M, Martin B, Punnett L, Silverstein B, Sjögaard G, et al.: Musculoskeletal Disorders: Work-related Risk Factors and Prevention. Int J Occup Environ Health 1996, 2(3):239-246.
• [2]ILO International Labour Organization: Technical and ethical guidelines for workers' health surveillance. 1998.
• [3]Hagberg M, Christiani D, Courtney TK, Halperin W, Leamon TB, Smith TJ: Conceptual and definitional issues in occupational injury epidemiology. American journal of industrial medicine 1997, 32(2):106-115.
• [4]Katz JN, Stock SR, Evanoff BA, Rempel D, Moore JS, Franzblau A, Gray RH: Classification criteria and severity assessment in work-associated upper extremity disorders: methods matter. American journal of industrial medicine 2000, 38(4):369-372.
• [5]Heinegard D, Lidgren L, Saxne T: Recent developments and future research in the bone and joint decade 2000-2010. Bulletin of the World Health Organization 2003, 81(9):686-688.
• [6]Sluiter JK, Rest KM, Frings-Dresen MH: Criteria document for evaluating the work-relatedness of upper-extremity musculoskeletal disorders. Scandinavian journal of work, environment & health 2001, 27(Suppl 1):1-102.
• [7]Van Eerd D, Beaton D, Cole D, Lucas J, Hogg-Johnson S, Bombardier C: Classification systems for upper-limb musculoskeletal disorders in workers: a review of the literature. Journal of clinical epidemiology 2003, 56(10):925-936.
• [8]Andersen JH, Haahr JP, Frost P: Risk factors for more severe regional musculoskeletal symptoms: a two-year prospective study of a general working population. Arthritis and rheumatism 2007, 56(4):1355-1364.
• [9]Palmer KT, Harris EC, Linaker C, Cooper C, Coggon D: Optimising case definitions of upper limb disorder for aetiological research and prevention: a review. Occupational and environmental medicine 2012, 69(1):71-78.
• [10]van Rijn RM, Huisstede BM, Koes BW, Burdorf A: Associations between work-related factors and specific disorders of the shoulder–a systematic review of the literature. Scandinavian journal of work, environment & health 2010, 36(3):189-201.
• [11]Roquelaure Y, Ha C, Leclerc A, Touranchet A, Sauteron M, Melchior M, Imbernon E, Goldberg M: Epidemiologic surveillance of upper-extremity musculoskeletal disorders in the working population. Arthritis and rheumatism 2006, 55(5):765-778.
• [12]Roquelaure Y, Ha C, Rouillon C, Fouquet N, Leclerc A, Descatha A, Touranchet A, Goldberg M, Imbernon E: Risk factors for upper-extremity musculoskeletal disorders in the working population. Arthritis and rheumatism 2009, 61(10):1425-1434.
• [13]Smith CK, Bonauto DK, Silverstein BA, Wilcox D: Inter-rater reliability of physical examinations in a prospective study of upper extremity musculoskeletal disorders. Journal of occupational and environmental medicine/American College of Occupational and Environmental Medicine 2010, 52(10):1014-1018.
• [14]Spreeuwers D, de Boer AG, Verbeek JH, van Dijk FJ: Evaluation of occupational disease surveillance in six EU countries. Occupational medicine 2010, 60(7):509-516.
• [15]Palmer KT, Harris EC, Linaker C, Barker M, Lawrence W, Cooper C, Coggon D: Effectiveness of community- and workplace-based interventions to manage musculoskeletal-related sickness absence and job loss: a systematic review. Rheumatology 2012, 51(2):230-242.
• [16]Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, et al.: Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003, 106(3):337-345.
• [17]Ilmarinen J: Work ability–a comprehensive concept for occupational health research and prevention. Scandinavian journal of work, environment & health 2009, 35(1):1-5.
• [18]Lerner D, Amick BC: Rogers WH, Malspeis S, Bungay K, Cynn D: The Work Limitations Questionnaire. Medical care 2001, 39(1):72-85.
• [19]Durand MJ, Vachon B, Hong QN, Imbeau D, Amick BC: Loisel P: The cross-cultural adaptation of the Work Role Functioning Questionnaire in Canadian French. International journal of rehabilitation research Internationale Zeitschrift fur Rehabilitationsforschung Revue internationale de recherches de readaptation 2004, 27(4):261-268.
• [20]Descatha A, Roquelaure Y, Chastang JF, Evanoff B, Melchior M, Mariot C, Ha C, Imbernon E, Goldberg M, Leclerc A: Validity of Nordic-style questionnaires in the surveillance of upper-limb work-related musculoskeletal disorders. Scandinavian journal of work, environment & health 2007, 33(1):58-65.
• [21]Kuorinka I, Jonsson B, Kilbom A, Vinterberg H, Biering-Sorensen F, Andersson G, Jorgensen K: Standardised Nordic questionnaires for the analysis of musculoskeletal symptoms. Appl Ergon 1987, 18(3):233-237.
• [22]Hudak PL, Amadio PC: Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). American journal of industrial medicine 1996, 29(6):602-608.
• [23]Viikari-Juntura E, Kausto J, Shiri R, Kaila-Kangas L, Takala EP, Karppinen J, Miranda H, Luukkonen R, Martimo KP: Return to work after early part-time sick leave due to musculoskeletal disorders: a randomized controlled trial. Scandinavian journal of work, environment & health,  ; 2011.
• [24]van den Berg TI, Elders LA, de Zwart BC, Burdorf A: The effects of work-related and individual factors on the Work Ability Index: a systematic review. Occupational and environmental medicine 2009, 66(4):211-220.
• [25]Ahlstrom L, Grimby-Ekman A, Hagberg M, Dellve L: The work ability index and single-item question: associations with sick leave, symptoms, and health–a prospective study of women on long-term sick leave. Scandinavian journal of work, environment & health 2010, 36(5):404-412.
• [26]van Veldhoven MJ, Sluiter JK: Work-related recovery opportunities: testing scale properties and validity in relation to health. Int Arch Occup Environ Health 2009, 82(9):1065-1075.
• [27]Coggon D, Martyn C, Palmer KT, Evanoff B: Assessing case definitions in the absence of a diagnostic gold standard. International journal of epidemiology 2005, 34(4):949-952.
• [28]Gold JE: d'Errico A, Katz JN, Gore R, Punnett L: Specific and non-specific upper extremity musculoskeletal disorder syndromes in automobile manufacturing workers. American journal of industrial medicine 2009, 52(2):124-132.
• [29]Wind H, Gouttebarge V, Kuijer PP, Sluiter JK, Frings-Dresen MH: The utility of functional capacity evaluation: the opinion of physicians and other experts in the field of return to work and disability claims. Int Arch Occup Environ Health 2006, 79(6):528-534.
• [30]Quintner JL: The Australian RSI debate: stereotyping and medicine. Disabil Rehabil 1995, 17(5):256-262.
• [31]Williams AE, Smith WR, Starr AJ, Webster DC, Martinez RJ, Vojir CP, Sakalys JA, Morgan SJ: Ethnic differences in posttraumatic stress disorder after musculoskeletal trauma. J Trauma 2008, 65(5):1054-1065.
• [32]Bhattacharya A, Leigh JP: Musculoskeletal disorder costs and medical claim filing in the US retail trade sector. Ind Health 2011, 49(4):517-522.
• [33]Westgaard RH, Winkel J: Occupational musculoskeletal and mental health: Significance of rationalization and opportunities to create sustainable production systems - A systematic review. Appl Ergon 2011, 42(2):261-296.